Megestrol Healthcare Med

Megestrol acetate, the active ingredient in Megestrol Healthcare Med, is a synthetic progestin presented as an oral tablet for oral use. It is employed as an appetite stimulant in patients with cachexia and as hormone therapy for certain hormone‑sensitive cancers.

GNH USA supplies Megestrol Healthcare Med as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres and pharmacies worldwide.

Megestrol acetate is used in clinical settings that involve hormone‑dependent conditions and severe weight loss.

- Cachexia: improves appetite and promotes weight gain in patients with cancer‑related wasting. - Advanced breast cancer: provides antigonadotropic effects to help control tumor growth. - Endometrial cancer: acts as a hormonal therapy to inhibit disease progression.

Megestrol acetate may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Edema: swelling of the lower extremities. - Weight gain: due to increased appetite and fluid retention. - Fatigue: general feeling of tiredness. - Mood changes: irritability or depression. - Hyperglycemia: elevated blood sugar levels.

Serious or Rare Side Effects: - Thromboembolic events: deep vein thrombosis or pulmonary embolism. - Adrenal suppression: reduced endogenous cortisol production. - Hepatotoxicity: liver enzyme abnormalities. - Severe allergic reactions: rash, itching, swelling. - Cushingoid features: facial rounding, central obesity. - Menstrual irregularities: abnormal bleeding patterns.

When prescribing Megestrol acetate, clinicians should consider several safety measures.

- Monitor blood glucose: patients with diabetes may require dose adjustments. - Assess thrombotic risk: avoid in individuals with a history of clotting disorders. - Evaluate liver function: periodic tests recommended for patients with hepatic disease. - Watch for adrenal insufficiency: taper off gradually after long‑term use. - Pregnancy and lactation: avoid use due to unknown safety profile. - Store at ambient temperature: keep below 25°C in the original container, protect from moisture and direct sunlight.

Megestrol acetate can interact with other medicines, affecting efficacy or safety.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): may increase bleeding risk. - CYP3A4 inducers (e.g., rifampin, carbamazepine): can reduce Megestrol levels. - Strong glucocorticoids: additive adrenal suppression.

Moderate Interactions (Monitor Closely): - Antidiabetic agents: may require dose adjustment due to hyperglycemia. - Hormonal therapies (e.g., tamoxifen): potential antagonistic effects. - NSAIDs: increased risk of gastrointestinal irritation.